HealthSTAT News
STAT+: Seattle scientists launch $95 million AI biology effort
Ultragenyx drug fails pivotal Phase 3, FDA's success at regulating unproven stem cells, and other biotech news
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
Ultragenyx drug fails pivotal Phase 3, FDA's success at regulating unproven stem cells, and other biotech news
Join the argument
House rules →Comments load as you scroll.